Wave Life Sciences Ltd (NASDAQ:WVE) has a beta value of -1.25 and has seen 1.0 million shares traded in the last trading session. The company, currently valued at $2.14B, closed the last trade at $13.84 per share which meant it gained $0.05 on the day or 0.36% during that session. The WVE stock price is -15.03% off its 52-week high price of $15.92 and 74.71% above the 52-week low of $3.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.25 million shares traded. The 3-month trading volume is 1.65 million shares.
The consensus among analysts is that Wave Life Sciences Ltd (WVE) is Buy stock at the moment, with a recommendation rating of 1.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Sporting 0.36% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the WVE stock price touched $13.84 or saw a rise of 6.3%. Year-to-date, Wave Life Sciences Ltd shares have moved 174.06%, while the 5-day performance has seen it change -6.49%. Over the past 30 days, the shares of Wave Life Sciences Ltd (NASDAQ:WVE) have changed 72.14%. Short interest in the company has seen 4.89 million shares shorted with days to cover at 2.04.
Wall Street analysts have a consensus price target for the stock at $19, which means that the shares’ value could jump 27.16% from current levels. The projected low price target is $15.0 while the price target rests at a high of $22.0. In that case, then, we find that the current price level is -58.96% off the targeted high while a plunge would see the stock gain -8.38% from current levels.
Wave Life Sciences Ltd (WVE) estimates and forecasts
Figures show that Wave Life Sciences Ltd shares have underperformed across the wider relevant industry. The company’s shares have gained 139.03% over the past 6 months, with this year growth rate of -87.04%, compared to 17.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 36.03% over the past 5 years.
WVE Dividends
Wave Life Sciences Ltd is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
Insiders own 15.79% of the company shares, while shares held by institutions stand at 66.31% with a share float percentage of 78.74%. Investors are also buoyed by the number of investors in a company, with Wave Life Sciences Ltd having a total of 195.0 institutions that hold shares in the company. The top two institutional holders are RA CAPITAL MANAGEMENT, L.P. with over 18.2 million shares worth more than $90.83 million. As of 2024-06-30, RA CAPITAL MANAGEMENT, L.P. held 14.0527% of shares outstanding.
The other major institutional holder is MAVERICK CAPITAL LTD, with the holding of over 7.67 million shares as of 2024-06-30. The firm’s total holdings are worth over $38.27 million and represent 5.9211% of shares outstanding.
